Neurodevelopmental Outcome of the Late Preterm Infant

Clinics in Perinatology

Volumn 33, Issue 4, 2006, Pages 947-964

  Adams Chapman, Ira ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN MATURATION; BRAIN PROTECTION; CEREBELLUM; ENCEPHALOMALACIA; GESTATION PERIOD; GESTATIONAL AGE; GRAY MATTER; HEALTH EDUCATION; HEARING IMPAIRMENT; HUMAN; INFANT; KERNICTERUS; LOW BIRTH WEIGHT; PERINATAL DEVELOPMENT; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; WHITE MATTER;

BRAIN; CEREBRAL HEMORRHAGE; DEVELOPMENTAL DISABILITIES; HEARING LOSS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; KERNICTERUS; LEUKOMALACIA, PERIVENTRICULAR; NEUROLOGIC EXAMINATION;

EID: 36849085256     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2006.09.004     Document Type: Review

References (50)

1. Guihard-Costa A.M., and Larroche J.C. Differential growth between the fetal brain and its infratentorial part. Early Hum Dev 23 (1990) 27-40
2. Kinney H.C. The near-term (late preterm) human brain and risk for periventricular leukomalacia: a review. Semin Perinatol 30 (2006) 81-88
3. Huppi P.S., Warfield S., Kikinis R., et al. Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann Neurol 43 (1998) 224-235
4. Samuelsen G.B., Larsen K.B., Bogdanovic N., et al. The changing number of cells in the human fetal forebrain and its subdivisions: a sterological analysis. Cereb Cortex 13 (2003) 115-122
5. Haynes R.L., Borenstein N.S., Desilva T.M., et al. Axonal development in the cerebral white matter of the human fetus and infant. J Comp Neurol 484 (2005) 156-167
6. Rezaie P., and Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 22 (2002) 106-132
7. Back S.A., Luo N.L., Borenstein N.S., et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 15 (2001) 1302-1312
8. Volpe J.J. Neurology of the newborn. 4th edition (2001), WB Saunders, Philadelphia
9. Limperopoulos C., Soul J.S., Gauvreau K., et al. Late gestation cerebellar growth is rapid and impeded by premature birth. Pediatrics 111 (2005) 688-695
10. Goyen T.A., Lui K., and Woods R. Visual-motor, visual-perceptual, and fine motor outcomes in very low birth weight children at 5 years. Dev Med Child Neurol 40 (1998) 76-81
11. Allin M., Matsumoto H., Santhouse A.M., et al. Cognitive and motor function and the size of the cerebellum in adolescents born very prematurely. Brain 124 (2001) 60-66
12. Aylward G.P. Cognitive and neuropsychological outcomes: more than IQ scores. Ment Retard Dev Disabil Res Rev 8 (2002) 234-240
13. Hadders-Algra M., Huisjes J.H., and Touwen B.C. Perinatal risk factors and minor neurological dysfunction: significance for behavior and school achievement at nine years. Dev Med Child Neurol 30 (1988) 482-491
14. Grunnet M.L., and Shilds W.D. Cerebellar hemorrhage in the premature infant. J Pediatr 88 (1976) 605-608
15. Armstrong D.L., Hay M., and Terrian D.M. Modulation of cerebellar granule cell activity by iontophoretic application of serotonergic agents. Brain Res Bull 19 (1987) 699-704
16. Argyropoulou M.I., Xydis V., Drougia A., et al. MRI measurements of the pons and cerebellum in children born preterm; associations with the severity of periventricular leukomalacia and perinatal risk factors. Neuroradiology 45 (2003) 730-734
17. Morse SB, Tang Y, Roth J. Abstract 4355. Pediatric Research Supplement 2006;158.
18. Folkerth R.D., Haynes R.L., Borenstein N.S., et al. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated human telencephalic white matter. J Neuropathol Exp Neurol 63 (2004) 990-999
19. Haynes R.L., Borenstein N., Desilva T.M., Folkerth R.D., Liu L.G., and Volpe J.J. Developmental lag of superoxide dismutases relative to another antioxidant enzymes in premyelinated human telenccephalic white matter. J Neuropathol Exp Neurol 14 (2004) 265-274
20. Miller S.P., Vigneron D.B., Henry R.G., et al. Serial quantitative diffusion tensor MRI of the premature brain: Development in newborns with and without injury. J Magn Reson Imaging 16 (2002) 621-632
21. Huppi P.S., Murphy B., Maier S.E., et al. Microstructural brain Development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics 107 (2001) 455-460
22. Neil J., Miller J., Mukherjee P., et al. Diffusion tensor imaging of normal and injured developing human brain-a technical review. NMR Biomed 15 (2002) 543-552
23. Neil J.J., Shiran S.I., McKinstry R.C., et al. Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology 209 (1998) 57-66
24. Inder T.E., Huppi P.S., Warfield S., et al. Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol 46 (1999) 755-760
25. Adams-Chapman I., and Stoll B.J. Neonatal infection and long term neurodevelopmental outcome in the preterm. Curr Opin Infect Dis 19 (2006) 290-297
26. Bhutani V.K., and Johnson L. Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol 30 (2006) 89-97
27. Maisels M.J., Baltz R.D., Bhutani V.K., et al. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 114 (2004) 297-316
28. Sarici S.U., Serdar M.A., Korkmaz A., et al. Incidence, course and prediction of hyperbilirubinemia in near-term and term newborns. Pediatrics 113 (2004) 775-780
29. Newman T.B., Xiong B., Gonzales V.M., et al. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med 154 (2000) 1140-1147
30. Newman T.B., Liljestrand P., and Escobar G.J. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics 111 (2003) 1303-1311
31. Newman T.B., Liljestrand P., Jeremy R.J., et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 354 (2006) 1889-1900
32. Shapiro S.M. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 25 (2005) 54-59
33. Perlstein M. Neurologic sequelae of erythroblastosis fetalis. Am J Dis Child 79 (1950) 605-606
34. Fernandes A., Silva R.F.M., Falcao A.S., et al. Cytokine production, glutamate release and cell death in rat cultures astrocytes with unconjugated bilirubin and LPS. J Neuroimmunol 153 (2004) 64-75
35. Wennberg R.P., and Hance A.J. Experimental bilirubin encephalopathy: importance of total bilirubin, protein binding and blood-brain-barrier. Pediatr Res 20 (1986) 789-792
36. Wennberg R.P. Animal models of bilirubin encephalopathy. Adv Vet Sci Comp Med 37 (1993) 87-113
37. Wennberg R.P., Ahlfors C.E., Bhutani V.K., et al. Toward Understanding Kernicterus: A challenge to improve the management of jaundiced newborns. Pediatrics 117 (2006) 474-485
38. Falcao A.S., Fernandes A., Brito M.A., et al. Bilirubin-induced inflammatory response, glutamate release, and cell death in rat cortical astrocytes are enhanced in younger cells. Neurobiol Dis 20 (2005) 199-206
39. Bhutani V.K., Johnson L., and Sivieri E.M. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near term newborns. Pediatrics 103 (1999) 6-14
40. Brown A.K., Damus K., Kim M.H., et al. Factors relating to readmission of term and near-term neonates in the first two weeks of life. Early Discharge Survey Group of the Health Professional Advisory Board of the Greater New York Chapter of the March of Dimes. J Perinat Med 27 (1999) 263-275
41. Soorani-Lunsing I., Woltil H.A., and Hadders-Algra M. Are moderate degrees of hyperbilirubinemia in healthy term neonates really safe for the brain?. Pediatr Res 50 (2001) 701-705
42. Harris M.C., Bernbaum J.C., Polin J.R., et al. Developmental follow-up of breastfed term and near term infants with marked hyperbilirubinemia. Pediatrics 107 (2001) 1075-1080
43. Newman T.B., and Klebanoff M. 33,272 Infants, 7-year follow-up: total serum bilirubin, transfusion reexamined. Pediatrics 110 (2002) 1032
44. Gupta A.K., and Mann S.B. Is auditory brainstem response a bilirubin toxicity marker?. Am J Otolaryngol 19 (1998) 232-236
45. Chisin R., Perlman M., and Sohmer H. Cochlear and brain stem responses in hearing loss following neonatal hyperbilirubinemia. Ann Otol Rhinol Laryngol 88 (1979) 352 [Check page numbers.]
46. Starr A., Picton T.W., Sininger Y., et al. Auditory neuropathy. Brain 119 (1996) 741-753
47. Berlin C.I., Hood L., Morlet T., et al. Auditory neuropathy/dys-synchrony: diagnosis and management. Ment Retard Dev Disabili Res Rev 9 (2003) 225-231
48. Rance G., Beer D.E., Cone-Wesson B., et al. Clinical findings for group of infants and young children with auditory neuropathy. Ear Hear 20 (1999) 238-252
49. Sininger Y. Overview of auditory neuropathy. Audiology Online. Available at: http://www.audiologyonline.com.
50. McCormick M.C., Brooks-Gunn J., Buka S.L., et al. Early intervention in low birth weigh premature infants: results at 18 years of age for the Infant Health and Development Program. Pediatrics 117 (2006) 771-780